The Technical Analyst
Select Language :
Esperion Therapeutics Inc [ESPR]

Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

Esperion Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Esperion Therapeutics Inc is listed at the  Exchange

2.29% $2.68

America/New_York / 28 mar 2024 @ 16:00


Esperion Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 456.72 mill
EPS: -2.03
P/E: -1.320
Earnings Date: May 06, 2024
SharesOutstanding: 170.42 mill
Avg Daily Volume: 6.38 mill
RATING 2024-03-28
C+
Sell
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Strong Buy
Return On Asset: Sell
DE: Strong Sell
P/E: Sell
Price To Book: Strong Sell
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -1.320 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.03x
Company: PE -1.320 | industry: PE 47.78
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 2.44 - 2.92

( +/- 8.84%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-14 Warren Eric Buy 100 000 Common Stock
2024-03-14 Warren Eric Buy 150 000 Stock Option (right to buy)
2024-03-14 Foody Joanne M. Buy 150 000 Common Stock
2024-03-14 Foody Joanne M. Buy 200 000 Stock Option (right to buy)
2024-03-14 Looker Benjamin Buy 100 000 Common Stock
INSIDER POWER
98.65
Last 98 transactions
Buy: 4 476 078 | Sell: 52 346

Forecast: 16:00 - $2.68

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $2.68
Forecast 2: 16:00 - $2.68
Forecast 3: 16:00 - $2.68
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.68 (2.29% )
Volume 8.16 mill
Avg. Vol. 6.38 mill
% of Avg. Vol 127.98 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Esperion Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Esperion Therapeutics Inc

RSI

Intraday RSI14 chart for Esperion Therapeutics Inc

Last 10 Buy & Sell Signals For ESPR

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$2.60N/AActive
Profile picture for
            Esperion Therapeutics Inc

ESPR

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

Last 10 Buy Signals

Date Signal @
WNEARUSDMar 29 - 09:237.06
BIFIUSDMar 29 - 09:18438.25
MSOLUSDMar 29 - 09:18218.45
DPXUSDMar 29 - 09:1942.00
INVUSDMar 29 - 09:1563.76
DEGOUSDMar 29 - 09:153.56
PSGUSDMar 29 - 09:155.23
XAUTUSDMar 29 - 09:15$2 230.55
TRIASUSDMar 29 - 09:1412.54
MLKUSDMar 29 - 09:150.401

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.